|
Indication |
To prevent infection with Corynebacterium
diphtheriae and Clostridium tetani. |
|
Proprietary Name |
DT (generic) |
|
Manufacturer |
sanofi pasteur |
|
Viability |
Inactivated |
|
Approved
Ages |
≤ 7 years |
|
Dose |
0.5 mL |
|
Route |
Intramuscular |
|
Dose form |
Suspension |
|
Appearance |
Turbid liquid, white, slightly gray |
|
Concentration (per 0.5 mL) |
Diphtheria, 6.7 Lf U
Tetanus, 5 LF U |
|
Excipients |
Aluminum, ≤
0.17 mg
Bovine Extract, amount not specified in
Package Insert
Formaldehyde, <0.02%
|
|
Adjuvant |
Aluminum potassium sulfate, ≤
0.17 mg aluminum |
|
Allergens |
Stopper to the vial contains dry natural latex rubber
Thimerosal, ≤0.3 mcg mercury |
|
Preservatives |
Thimerosal, ≤0.3
mcg mercury
|
|
Media |
Modified Mueller and Miller
Pepton-based medium containing bovine
extract |
|
Packaging |
Single-dose (0.5 mL) vials - 10 per package |
|
Routine storage |
2 to 8°
C (36-46°
F)
Do Not Freeze |
|
Package Insert Date |
December 2005 |
|
updated January 2012 |
|

This page
was last updated on
April 05, 2012
© 2012
Institute for Vaccine Safety |